It was discussed in relation to the decline in US life expectancy and the issues with the US healthcare system, particularly the role of Big Pharma.
What it tells us is that our health care is very fragile and that the covid epidemic pandemic has stressed our health care but the decrease in longevity for Americans over the past couple of years is...
— Episode: 9/1/22: Trump Investigation, Biden Messa...
Episode: 9/1/22: Trump Investigation, Biden Messaging, Midt...
It was discussed in relation to the decline in US life expectancy and the issues with the US healthcare system, particularly the role of Big Pharma.
What it tells us is that our health care is very fragile and that the covid epidemic pandemic has stressed our health care but the decrease in longevity for Americans over the past couple of years is not entirely due to Covid at all. It's largely due to the weakness, not the greatness, of our health care system.
In countries like France and Germany and Canada they negotiate the price of drugs on the front end based on the effectiveness of the drugs but we have no mechanism for determining the effectiveness of new drugs compared to other drugs and we let drug companies charge whatever they want.
Two-thirds of the profits from the drug global profits from the drug companies now come from the United States and this system not only pulls money away from Americans either out of their pockets or through their tax tax dollars but it allows the drug companies to promote drugs that are no more effective than older therapies as if they were so it's distracting our health care.
The key fact here that's being covered up by the inflation reduction act is that limiting insulin copays to 35 dollars is going to be a good thing for insured folks who require insulin who don't have enough money to pay their copays. That's a good thing, but the bad thing is that as the California project comes online or the Michigan project comes online and makes 35 dollar insulin 35 dollar analog insulin what's going to happen is the drug companies, the brand-name drugs, are going to say, 'Hey, don't let your doctor shift you down to an inferior generic product when you're doing well on the brand-name insulin, stay with us because it's only going to cost you a 35 dollar copay.'
The real issue underlying this that nobody talks about because I've got a chapter on this in my book is that 80% of the insulin that's used in the United States is used by people with type two diabetes and there is no evidence that the insulin analogs that cost 300 dollars a vial are superior than the first generation of bioengineered insulin, recombinant human insulin, which does cost 35, 25 dollars a vial when it's bought efficiently.
Episode: 2/7/22: Breakdown of the Rogan Controversy, Gofund...
It was discussed in detail, and its author was a guest on the show. The book exposes how big pharma has manipulated the American healthcare system.
We both heard him on the Joe Rogan podcast. The racist Joe Rogan podcast. Which is where we will start this morning.
Really excited to read the book haven't had that chance yet but we have Dr. Abramson here in order to break some of this down.
This is something where he appeared on the Joe Rogan Experience and Krystal and I were absolutely stunned by how good of an episode it was.
Episode: 2/7/22: Breakdown of the Rogan Controversy, Gofund...
It was discussed at length, with the authors praising the book's insights into how Big Pharma has impacted the American healthcare system. They were impressed by a past podcast episode featuring the author.
We've been working on getting him on the show for a while. He wrote a book called Sickening. We both heard him on the Joe Rogan podcast.
This is something where he appeared on the Joe Rogan experience and Krystal and I were absolutely stunned by how good of an episode it was. Really excited to read the book, haven't had that chance yet, but we have Dr. Abramson here in order to break some of this down.
Episode: 9/1/22: Trump Investigation, Biden Messaging, Midt...
It was discussed in the context of the US healthcare system and the decline in life expectancy, with the author being an expert on Big Pharma and the pharmaceutical industry.
What it tells us is that our health care is very fragile and that the COVID epidemic pandemic has stressed our health care but the decrease in longevity for Americans over the past couple of years is not entirely due to COVID at all. It's largely due to the weakness, not the greatness, of our health care system.
The key fact here that's being covered up by the inflation reduction act is that limiting insulin copays to $35 is going to be a good thing for insured folks who require insulin, who don't have enough money to pay their copays. That's a good thing, but the bad thing is that as the California project comes online or the Michigan project comes online and makes $35 insulin, $35 analog insulin, what's going to happen is the drug companies, the brand name drugs are going to say, 'Hey, don't let your doctor shift you down to an inferior generic product when you're doing well on the brand name insulin. Stay with us because it's only going to cost you a $35 copay.' So what's going to happen is that that $35 limit to the copay is going to largely neutralize the market benefits of California or Michigan selling insulin analogs at cost.
Episode: 2/7/22: Breakdown of the Rogan Controversy, Gofund...
It was discussed in detail, with the authors highlighting how it exposed the ways in which Big Pharma has allegedly manipulated the American healthcare system, particularly regarding drug trials and knowledge dissemination to doctors.
We both heard him on the Joe Rogan podcast. The racist Joe Rogan podcast.
This is something where he appeared on the Joe Rogan experience and Krystal and I were absolutely stunned by how good of an episode it was.
Really excited to read the book, haven't had that chance yet, but we have Dr. Abramson here in order to break some of this down.